A. Prasad et al., Dehydroepiandrosterone-mediated decrease in caloric intake by obese Zuckerrats is not due to changes in serum entrostatin-like immunoreactivity, PHYSL BEHAV, 68(3), 2000, pp. 341-345
To understand the mechanism(s) of appetite modulation by DHEA, we have unde
rtaken a series of studies to examine the effects of DHEA on neurotransmitt
ers and neuropeptides known to affect appetitive behavior. Here, we report
the effect of DHEA on serum enterostatin-VPDPR or E, a pentapeptide known t
o cause selective diminution in fat intake. Four-week-old lean (fa/+) and o
bese (fa/fa) Zucker rats were divided into control and treatment groups. DH
EA-treated groups received powdered chow containing 0.6% DHEA ad lib for 16
weeks. Another group of obese rats was pair fed to match the intake of the
obese DHEA-treated rats. At the end of this period, trunk blood was collec
ted from fasted rats for assay of E-like immunoreactivity (E-LI) by ELISA.
DHEA treatment caused a significant diminution in circulating E-LI in both
lean (control: 2030 +/- 226; treated: 752 +/- 145 ng/mL; n = 10, p < 0.0001
) and obese (control: 2489 +/- 391, n = 6; treated: 1123 +/- 185 ng/mL, n =
7; p = 0.0003) rats. Because DHEA treatment decreases caloric intake and b
ody weight, we examined the effect of caloric intake and body weight on E-L
I levels. Serum ELI levels were lower in the obese DHEA-treated group compa
red to that of obese pair fed (pair fed: 1589 +/- 313, n = 6; DHEA: 1123 +/
- 185 ng/mL, it = 7), but the differences were statistically insignificant
(p = 0.185). Also, both weight-matched lean and obese control rats had sign
ificantly (p < 0.008) higher E-LI than their DHEA-treated counterparts. To
examine whether the decrease in serum E-LI following DHEA treatment could b
e due to increased peptide metabolism, the rate of disappearance of endogen
ous E-LI from serum (obese control and DHEA-treated) at 37 degrees C was ev
aluated. The results show an attenuation of peptide metabolism in serum fro
m DHEA-treated rats, a finding contrary to our expectations. In summary, DH
EA treatment lowers serum E-LI levels both in lean and obese Zucker rats. T
his decrement in peptide level is not secondary to changes in body weight o
r caloric intake due to DHEA, or due to altered serum peptide metabolism. A
lthough DHEA appears to be a potent modulator of E-LI levels, the relations
hip between DHEA and E-LI in relation to appetitive behavior remains to be
clarified. (C) 2000 Elsevier Science Inc. All rights reserved.